Data were analyzed from 23 patients with Sezary syndrome (defined by erythr
oderma, more than 10% circulating atypical mononuclear cells, and periphera
l blood T-cell clone) undergoing monthly extracorporeal photopheresis as th
e sole therapy for up to 1 year. The cohort showed a significant reduction
of skin scores during treatment (P = .001). Thirteen patients (57%) achieve
d a reduction in skin score greater than 25% from baseline at 3, 6, 9, or 1
2 months (responders). Reduction in skin score correlated with reduction in
the Sezary cell count as a percentage of total white cell count (P = .03).
Responders and nonresponders were compared. None of the measured parameter
s was significantly different between the 2 groups. It was assessed whether
any of the baseline parameters predicted outcome. A higher baseline lympho
cyte count was significantly associated with a decrease in skin score at 6
months (P < .05). A higher baseline Sezary cell count as a percentage of to
tal white cell count predicted a subject was more likely to be a responder
after 6 months of treatment (P = .021). No other parameters predicted respo
nder status. These data show that the modest falls in CD4, CD8, and Sezary
cell counts were seen in all patients and might have resulted from lymphocy
te apoptosis. This mechanism could explain the more favorable response seen
in patients with higher percentages of Sezary cells in the peripheral bloo
d. Alternatively, minimum tumor burden might be required for the induction
of a cytotoxic response. Analysis of tumor-specific cytotoxic T cells is ne
eded to Investigate these possibilities further. (C) 2001 by The American S
ociety of Hematology.